Business Context and Reporting Period
Company: CollPlant Biotechnologies Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 25, 2021
Context: The filing announces the scheduling of an Annual and Extraordinary General Meeting of Shareholders to be held on August 4, 2021, in Tel-Aviv, Israel. The document serves to provide the Notice and Proxy Statement and a Proxy Card to shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document focuses solely on corporate governance procedures for the upcoming shareholder meeting.
Guidance, Outlook, and Risks
Management Commentary: The filing details the logistics for the General Meeting, including the date, time, and location (Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. law firm). It outlines the proposals to be voted upon and the procedures for voting in person or by proxy.
Risks and Contingencies: No specific risks, contingencies, or unusual items are discussed in this text.
Guidance: No financial guidance or outlook is provided.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the deadline and procedure for submitting proxy votes for the August 4, 2021 meeting.
- Note that this filing does not contain updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.